NCT06942936 - A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

February 6, 2026

Study Completion Date

February 6, 2026

Conditions

Healthy Participants

Interventions

DRUG

AZD5004

AZD50004 is administered orally as a tablet.

DRUG

Itraconazole

Itraconazole is administered orally as a capsule.

DRUG

EE/LNG

EE/LNG is administered orally in the form of tablet.

Trial Locations (2)

ACTIVE_NOT_RECRUITING

Research Site, Berlin

RECRUITING

Research Site, Baltimore